COSMO Pharmaceuticals Risk Adjusted Performance
| COPN Stock | | | CHF 75.80 -3.20 -4.05% |
The Risk Adjusted Performance signal for COSMO Pharmaceuticals SA reflects patterns observed in trading data. All inputs are based on actual trading observations from supported exchanges. COSMO Pharmaceuticals has a market cap of 1.08 B, operating margin of -2.73%, ROE of 12.34%. Review
Trending Equities for a broader allocation view. Portfolio composition is shown for contextual purposes. The allocation view reflects recorded position information. The portfolio reflects a holding in COSMO Pharmaceuticals SA. The weighting is visible within the allocation breakdown. The relative size of each holding follows the allocation framework. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
COSMO Pharmaceuticals SA has current Risk Adjusted Performance of
-0.08.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.08 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
COSMO Pharmaceuticals SA is rated
below average for risk adjusted performance across the peer group. It is currently under evaluation for maximum drawdown across the peer group .
Other Technical Indicators